Characterization of the Dynamics of Hepatitis B Virus Resistance to Adefovir by Ultra-Deep Pyrosequencing

被引:48
|
作者
Rodriguez, Christophe [1 ,2 ]
Chevaliez, Stephane [1 ,2 ]
Bensadoun, Paul [2 ]
Pawlotsky, Jean-Michel [1 ,2 ]
机构
[1] Univ Paris Est, Natl Reference Ctr Viral Hepatitis B C & Delta, Dept Virol, Hop Henri Mondor, Creteil, France
[2] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France
关键词
INNO-LIPA HBV; INFECTED PATIENTS; THERAPY; IDENTIFICATION; EPIDEMIOLOGY; POPULATIONS; NUCLEOSIDE; LAMIVUDINE; DIPIVOXIL; SELECTION;
D O I
10.1002/hep.26383
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis B virus (HBV) resistance to nucleoside/nucleotide analogs is frequent. Ultra-deep pyrosequencing (UDPS) is a powerful new tool that can detect minor viral variants and characterize complex quasispecies mixtures. We used UDPS to analyze the dynamics of adefovir-resistant HBV variants in patients with chronic HBV infection in whom adefovir resistance occurred during treatment. Amino acid substitutions known to confer resistance to adefovir were detected at baseline in most patients. The dynamics of adefovir-resistant variants were complex and differed among patients as a result of evolving differences in variant fitness. UDPS analysis revealed successive waves of selection of HBV populations with single and multiple amino acid substitutions. Adefovir-resistant variants were partially inhibited by lamivudine, but remained fit in its presence. Conclusion: Substitutions conferring HBV resistance to nucleoside/nucleotide analogs exist before treatment, and that the dynamics of adefovir-resistant populations are much more complex and heterogeneous than previously thought and involve thus far unknown amino acid substitutions. The UDPS-based approach described here is likely to have important implications for the assessment of antiviral drug resistance in research and clinical practice. (Hepatology 2013;53:890-901)
引用
收藏
页码:890 / 901
页数:12
相关论文
共 50 条
  • [31] Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing
    Guermouche, Helene
    Burrel, Sonia
    Mercier-Darty, Melanie
    Kofman, Thomas
    Rogier, Olivier
    Pawlotsky, Jean-Michel
    Boutolleau, David
    Rodriguez, Christophe
    ANTIVIRAL RESEARCH, 2020, 173
  • [32] Hepatitis B virus with primary resistance to adefovir - Reply
    Schildgen, Oliver
    Sirma, Hueseyin
    Gerlich, Wolfram
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03): : 323 - 323
  • [33] Analysis of Hepatitis C Virus NS5A Region in Patients with Cirrhosis Using an Ultra-Deep Pyrosequencing Method
    Keskin, Fahriye
    Ciftci, Sevgi
    Akyuz, Filiz
    Abaci, Neslihan
    Cakiris, Aris
    Akyuz, Umit
    Demir, Kadir
    Besisik, Fatih
    Ustek, Duran
    Kaymakoglu, Sabahattin
    CLINICAL LABORATORY, 2017, 63 (09) : 1439 - 1445
  • [34] Dynamics of hepatitis B virus resistance to adefovir dipivoxil unraveled by a thorough quasispecies analysis
    Pallier, Coralie
    Rodriguez, Christophe
    Brillet, Rozenn
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2006, 44 (04) : 565A - 566A
  • [35] Dynamics of Hepatitis B Virus Quasispecies in Association with Nucleos(t)ide Analogue Treatment Determined by Ultra-Deep Sequencing
    Nishijima, Norihiro
    Marusawa, Hiroyuki
    Ueda, Yoshihide
    Takahashi, Ken
    Nasu, Akihiro
    Osaki, Yukio
    Kou, Tadayuki
    Yazumi, Shujiro
    Fujiwara, Takeshi
    Tsuchiya, Soken
    Shimizu, Kazuharu
    Uemoto, Shinji
    Chiba, Tsutomu
    PLOS ONE, 2012, 7 (04):
  • [36] Ultra-Deep Pyrosequencing Detects Conserved Genomic Sites and Quantifies Linkage of Drug-Resistant Amino Acid Changes in the Hepatitis B Virus Genome
    Rodriguez-Frias, Francisco
    Tabernero, David
    Quer, Josep
    Esteban, Juan I.
    Ortega, Israel
    Domingo, Esteban
    Cubero, Maria
    Camos, Silvia
    Ferrer-Costa, Carles
    Sanchez, Alex
    Jardi, Rosendo
    Schaper, Melanie
    Homs, Maria
    Garcia-Cehic, Damir
    Guardia, Jaume
    Esteban, Rafael
    Buti, Maria
    PLOS ONE, 2012, 7 (05):
  • [37] PREVALENCE OF NUCLEOSIDE/NUCLEOTIDE ANALOGUE RESISTANCE AMONG TREATMENT-NAIVE ENDEMICALLY-EXPOSED CHRONIC HEPATITIS B INDIVIDUALS BY ULTRA-DEEP PYROSEQUENCING
    Osiowy, Carla
    Ng, Karen A.
    Ho, John
    Liang, Ben
    Wong, David K.
    Van Domselaar, Gary
    Heathcote, E. Jenny
    HEPATOLOGY, 2011, 54 : 1067A - 1068A
  • [38] Susceptibility of Hepatitis B Virus to Lamivudine Restored by Resistance to Adefovir
    Zaaijer, H. L.
    Takkenberg, R. B.
    Weegink, C. J.
    Rebers, S. P. H.
    Menting, S.
    Reesink, H. W.
    Schinkel, J.
    Molenkamp, R.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (03) : 413 - 416
  • [39] Primary resistance of a novel hepatitis B virus variant to adefovir
    Schildgen, O.
    Sirma, H.
    Funk, A.
    Wend, U. C.
    Hartmann, H.
    Olotu, C.
    Helm, M.
    Rockstroh, J. K.
    Willems, W. R.
    Will, H.
    Gerlich, W. H.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S91 - S91
  • [40] Primary resistance of a novel hepatitis B virus variant to adefovir
    Schildgen, O.
    Sirma, H.
    Funk, A.
    Wend, U. C.
    Hartman, H.
    Olotu, C.
    Helm, M.
    Willems, Wr.
    Will, H.
    Gerlich, W. H.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S190 - S190